EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer

Dawn Sijin Nin iD, Lih-Wen Deng iD

Cells · 2023

DOI: 10.3390/cells12060926 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Dawn Sijin Nin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, MD 7, 8 Medical Drive, Singapore 117596, Singapore. Hauptthemen laut MEDLINE: Testis, Neoplasms. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 232 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National University Health System Singapore, Ministry of Education Singapore, Academic Research Fund Tier 2 (MOE-AcRF-Tier 2).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumour-specific antigens have been an area of interest in cancer therapy since their discovery in the middle of the 20th century. In the era of immune-based cancer therapeutics, redirecting our immune cells to target these tumour-specific antigens has become even more relevant. Cancer-testis antigens (CTAs) are a class of antigens with an expression specific to the testis and cancer cells. CTAs have also been demonstrated to be expressed in a wide variety of cancers. Due to their frequency and specificity of expression in a multitude of cancers, CTAs have been particularly attractive as cancer-specific therapeutic targets. There is now a rapid expansion of CTAs being identified and many studies have been conducted to correlate CTA expression with cancer and therapy-resistant phenotypes. Furthermore, there is an increasing number of clinical trials involving using some of these CTAs as molecular targets in pharmacological and immune-targeted therapeutics for various cancers. This review will summarise the current knowledge of the biology of known CTAs in tumorigenesis and the regulation of CTA genes. CTAs as molecular targets and the therapeutic implications of these CTA-targeted anticancer strategies will also be discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TestisNeoplasmsMaleHumansAntigens, NeoplasmCarcinogenesisBiology

Stichwörter der Autor:innen

CT antigenscancercancer-testis antigens

Substanzen

Antigens, Neoplasm

Autor:innen und Institutionen

  • Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, MD 7, 8 Medical Drive, Singapore 117596, Singapore.
  • NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, 14 Medical Drive, Singapore 117599, Singapore.
  • National University Cancer Institute, National University Health System, 5 Lower Kent Ridge Road, Singapore 119074, Singapore.

ORCID-Profile: Dawn Sijin Nin, Lih-Wen Deng

Förderung

  • National University Health System Singapore
  • Ministry of Education Singapore, Academic Research Fund Tier 2 (MOE-AcRF-Tier 2)

Zitieren

APA

Nin, D. S., & Deng, L. W. (2023). Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer. Cells. https://doi.org/10.3390/cells12060926

Vancouver

Nin DS, Deng LW. Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer. Cells. 2023. doi:10.3390/cells12060926

BibTeX
@article{Nin2023,
  author = {Nin, Dawn Sijin and Deng, Lih-Wen},
  title = {Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12060926}
}
Kostenlos starten →